Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 3c; Guides In-Line
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Zimmer Biomet (ZBH) PT Raised to $132 at Oppenheimer Following 4Q Report
February 1, 2017 10:51 AM ESTOppenheimer raised its price target on Zimmer Biomet (NYSE: ZBH) to $132.00 (from $126.00) while maintaining a Outperform rating.
Analyst Steven Lichtman commented, "4Q16 sales of $2.013B (+3.0% organic, ex-stocking/FX, day-adjusted) were in line with ZBH's above consensus pre-announcement earlier in January; recall Americas... More
